| Cite this article: |
| SUN Shanpeng,YANG Fengming,ZHANG Xiaohan,FENG Tingting,YUAN Xizhe,LI Shangbin.Research progress on the mechanism of inflammation response mediated by cGAS-STING signaling pathway in immune and inflammation related diseases[J].Journal Of Pharmaceutical Research,2025,44(11):1,110-1,118[Click to copy] |
|
| This article has been viewed: 2048times Download 810次 |
 Scan with your phone! |
| cGAS-STING信号通路介导的炎症反应在免疫与炎症相关疾病中的作用机制研究进展 |
| 孙善鹏1,2,杨凤鸣1,2,张晓涵1,2,冯婷婷1,2,苑锡哲1,2,李尚滨3 |
|
|
| (1.山东第一医科大学附属省立医院全科医学科,山东 济南 250021;2.山东第一医科大学,山东 济南 250117;3.山东第一医科大学附属省立医院保健工作办公室,山东 济南 250021) |
|
| 摘要: |
| 环鸟嘌呤-腺嘌呤核苷酸合成酶(cGAS)-干扰素基因刺激蛋白(STING)信号通路是机体识别胞质DNA并启动先天免疫应答的关键机制,通过cGAS识别异常DNA合成环鸟苷酸-腺苷酸(cGAMP)激活STING,诱导I型干扰素(IFN-I)和促炎细胞因子表达,发挥抗病毒、抗菌及抗肿瘤免疫作用。然而,其异常激活可引发慢性炎症和自身免疫疾病。本文综述了cGAS-STING信号通路的组成及生物学功能,包括cGAS的结构与功能、STING的信号转导机制以及cGAMP与STING结合后的激活过程,探讨了该通路在炎症反应中的双重作用,并分析了其在自身免疫性疾病、炎症性疾病、感染性疾病及肿瘤免疫中的复杂作用机制。此外,本文还总结了cGAS-STING信号通路的多层次调控机制,包括转录水平、翻译后修饰及细胞器微环境的调控,以及基于该通路的潜在靶点及治疗策略,如cGAS拮抗剂、STING抑制剂等。最后,提出了未来研究方向,包括精细化调控机制、STING的功能拓展、与免疫微环境的相互作用以及靶向调控策略的优化。深入研究cGAS-STING信号通路的调控机制及其在疾病中的作用,有望为相关疾病的精准治疗提供新思路和靶点。 |
| 关键词: 环鸟嘌呤-腺嘌呤核苷酸合成酶-干扰素基因刺激蛋白信号通路 炎症反应 自身免疫性疾病 调控机制 |
| DOI:10.13506/j.cnki.jpr.2025.11.011 |
| 基金项目:山东省自然科学基金项目(No.ZR2021MH014) |
|
Publication Date:November 25, 2025
|
|
| Research progress on the mechanism of inflammation response mediated by cGAS-STING signaling pathway in immune and inflammation related diseases |
| SUN Shanpeng1,2,YANG Fengming1,2,ZHANG Xiaohan1,2,FENG Tingting1,2,YUAN Xizhe1,2,LI Shangbin3 |
| (1. Department of General Medicine, Affiliated Provincial Hospital of Shandong First Medical University, Jinan 250021, China; 2. Health Work Office of Shandong First Medical University Affiliated Provincial Hospital, Jinan 250021, China) |
| Abstract: |
| The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING) signaling pathway plays a pivotal role in the body's recognition of cytosolic DNA, triggering innate immune responses. By detecting aberrant DNA, cGAS synthesizes cGAMP, which activates STING and subsequently induces the expression of type I interferon(IFN-I) and pro-inflammatory cytokines, thus contributing to antiviral, antibacterial, and antitumor immunity. However, dysregulation of this pathway can lead to chronic inflammation and autoimmune diseases. This review explores the composition and biological functions of the cGAS-STING pathway, including the structure and function of cGAS, the signaling mechanisms of STING, and the activation process upon the binding of cGAMP to STING. We examine the dual roles of this pathway in inflammatory responses and analyze its complex involvement in autoimmune diseases, inflammatory conditions, infectious diseases, and cancer immunity. Furthermore, the review highlights the multi-layered regulatory mechanisms of the cGAS-STING pathway, encompassing transcriptional regulation, post-translational modifications, and modulation of organelle microenvironments. Potential therapeutic approaches targeting this pathway, including cGAS antagonists and STING inhibitors, are also discussed. Finally, we outline future research directions, emphasizing the refinement of regulatory mechanisms, the functional expansion of STING, its interaction with the immune microenvironment, and the optimization of targeted therapeutic strategies. A deeper understanding of the regulatory mechanisms governing the cGAS-STING pathway and its role in disease is poised to offer novel insights and therapeutic targets for the precision treatment of related diseases. |
| Key words: cGAS-STING signaling pathway Inflammatory response Autoimmune diseases Regulatory mechanisms |